Novel targeted immunotherapy approaches for staphylococcal infection

Bibliography

• Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520-32
   PubMed Web of Science ®Google Scholar
• Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 2003;111:1265-73
   PubMed Web of Science ®Google Scholar
• Kirby WM. Extraction of a highly potent penicillin inactivator from penicillin resistant Staphylococci. Science 1944;99:452-3
   PubMedGoogle Scholar
• Novick RP. Staphylococcal penicillinase and the new penicillins. Biochem J 1962;83:229-35
   PubMed Web of Science ®Google Scholar
• Stewart GT, Holt RJ. Evolution of natural resistance to the newer penicillins. Br Med J 1963;1:308-11
   PubMedGoogle Scholar
• DeLeo FR, Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest 2009;119:2464-74
   PubMed Web of Science ®Google Scholar
• Wertheim HF, Verbrugh HA. Global prevalence of meticillin-resistant Staphylococcus aureus. Lancet 2006;368:1866; author reply-1867
   PubMed Web of Science ®Google Scholar
• Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006;368:874-85
   PubMed Web of Science ®Google Scholar
• Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009;7:629-41
   PubMed Web of Science ®Google Scholar
• Moran GJ, Krishnadasan A, Gorwitz RJ, Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666-74
   PubMed Web of Science ®Google Scholar
• Witte W, Strommenger B, Cuny C, Methicillin-resistant Staphylococcus aureus containing the panton-valentine leucocidin gene in Germany in 2005 and 2006. J Antimicrob Chemother 2007;60:1258-63
   PubMed Web of Science ®Google Scholar
• Ruppitsch W, Stoger A, Schmid D, Occurrence of the USA300 community-acquired Staphylococcus aureus clone in Austria. Euro Surveill 2007;12(43):E0710251
   Google Scholar
• Klevens RM, Morrison MA, Nadle J, Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-71
   PubMed Web of Science ®Google Scholar
• Otto M. Staphylococcal biofilms. Curr Top Microbiol Immunol 2008;322:207-28
   PubMed Web of Science ®Google Scholar
• Diep BA, Chambers HF, Graber CJ, Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008;148:249-57
   PubMed Web of Science ®Google Scholar
• Voss A, Milatovic D, Wallrauch-Schwarz C, Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994;13:50-5
   PubMed Web of Science ®Google Scholar
• Molstad S, Cars O, Struwe J. Strama – a Swedish working model for containment of antibiotic resistance. Euro Surveill 2008;13(46):19041
   PubMedGoogle Scholar
• Sabuncu E, David J, Bernede-Bauduin C, Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 2009;6:e1000084
   PubMed Web of Science ®Google Scholar
• Wertheim HF, Melles DC, Vos MC, The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005;5:751-62
   PubMed Web of Science ®Google Scholar
• Williams RE. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963;27:56-71
   PubMedGoogle Scholar
• Takahashi N, Kato H, Imanishi K, Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen. J Clin Invest 2000;106:1409-15
   PubMed Web of Science ®Google Scholar
• Nomura Y, Yoshinaga M, Masuda K, Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome. J Infect Dis 2002;185:1677-80
   PubMed Web of Science ®Google Scholar
• Jensen K. A normally occurring Staphylococcus antibody in human serum. Acta Pathol Microbiol Scand 1958;44:421-8
   Google Scholar
• Wertheim HF, van Leeuwen WB, Snijders S, Associations between Staphylococcus aureus genotype, infection, and in-hospital mortality: a nested case-control study. J Infect Dis 2005;192:1196-200
   PubMed Web of Science ®Google Scholar
• Loffler B, Hussain M, Grundmeier M, Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 2010;6(1):e1000715
   PubMedGoogle Scholar
• Etz H, Minh DB, Henics T, Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci USA 2002;99:6573-8
   PubMed Web of Science ®Google Scholar
• Kuklin NA, Clark DJ, Secore S, A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun 2006;74:2215-23
   PubMed Web of Science ®Google Scholar
• Torres VJ, Pishchany G, Humayun M, Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J Bacteriol 2006;188:8421-9
   PubMed Web of Science ®Google Scholar
• Johri AK, Paoletti LC, Glaser P, Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 2006;4:932-42
   PubMed Web of Science ®Google Scholar
• O'Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev 2004;17:218-34
   PubMed Web of Science ®Google Scholar
• Fattom AI, Sarwar J, Ortiz A, Naso R. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect Immun 1996;64:1659-65
   PubMed Web of Science ®Google Scholar
• Lee JC, Park JS, Shepherd SE, Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect Immun 1997;65:4146-51
   PubMed Web of Science ®Google Scholar
• Shinefield H, Black S, Fattom A, Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002;346:491-6
   PubMed Web of Science ®Google Scholar
• Schaffer AC, Lee JC. Staphylococcal vaccines and immunotherapies. Infect Dis Clin North Am 2009;23:153-71
   PubMed Web of Science ®Google Scholar
• Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev 1991;55:733-51
   PubMedGoogle Scholar
• Liang X, Ji Y. Alpha-toxin interferes with integrin-mediated adhesion and internalization of Staphylococcus aureus by epithelial cells. Cell Microbiol 2006;8:1656-68
   Google Scholar
• Bubeck Wardenburg J, Bae T, Otto M, Poring over pores: alpha-hemolysin and panton-valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007;13(12):1405-6
   PubMed Web of Science ®Google Scholar
• Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun 1994;62:2478-82
   PubMed Web of Science ®Google Scholar
• Bramley AJ, Patel AH, O'Reilly M, Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect Immun 1989;57:2489-94
   PubMed Web of Science ®Google Scholar
• Patel AH, Nowlan P, Weavers ED, Foster T. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun 1987;55:3103-10
   PubMed Web of Science ®Google Scholar
• Poole-Warren LA, Hallett MD, Hone PW, Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial. Clin Nephrol 1991;35:198-206
   PubMed Web of Science ®Google Scholar
• Adlam C, Ward PD, McCartney AC, Effect immunization with highly purified alpha- and beta-toxins on staphylococcal mastitis in rabbits. Infect Immun 1977;17:250-6
   PubMed Web of Science ®Google Scholar
• Menzies BE, Kernodle DS. Site-directed mutagenesis of the alpha-toxin gene of Staphylococcus aureus: role of histidines in toxin activity in vitro and in a murine model. Infect Immun 1994;62:1843-7
   PubMed Web of Science ®Google Scholar
• Bubeck Wardenburg J, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 2008;205:287-94
   PubMed Web of Science ®Google Scholar
• Szmigielski S, Prevost G, Monteil H, Leukocidal toxins of staphylococci. Zentralbl Bakteriol 1999;289:185-201
   PubMedGoogle Scholar
• Diep BA, Otto M. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol 2008;16:361-9
   PubMed Web of Science ®Google Scholar
• Vandenesch F, Naimi T, Enright MC, Community-acquired methicillin-resistant Staphylococcus aureus carrying panton-valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003;9:978-84
   PubMed Web of Science ®Google Scholar
• Gillet Y, Issartel B, Vanhems P, Association between Staphylococcus aureus strains carrying gene for panton-valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002;359:753-9
   PubMed Web of Science ®Google Scholar
• Chheng K, Tarquinio S, Wuthiekanun V, Emergence of community-associated methicillin-resistant Staphylococcus aureus associated with pediatric infection in Cambodia. PLoS One 2009;4:e6630
   PubMed Web of Science ®Google Scholar
• Lee SS, Kim YJ, Chung DR, Invasive infection caused by community-associated methicillin-resistant Staphylococcus aureus strain not carrying panton-valentine leukocidin in Korea. J Clin Microbiol 2009;48:311-3
   PubMed Web of Science ®Google Scholar
• Nimmo GR, Coombs GW. Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. Int J Antimicrob Agents 2008;31:401-10
   PubMed Web of Science ®Google Scholar
• Rollason J, Bastin L, Hilton AC, Epidemiology of community-acquired meticillin-resistant Staphylococcus aureus obtained from the UK West Midlands region. J Hosp Infect 2008;70:314-20
   PubMed Web of Science ®Google Scholar
• Brown EL, Dumitrescu O, Thomas D, The panton-valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 2008;15:156-64
   PubMed Web of Science ®Google Scholar
• Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Panton-valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 2008;198:1166-70
   PubMed Web of Science ®Google Scholar
• Voyich JM, Otto M, Mathema B, Is panton-valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006;194:1761-70
   PubMed Web of Science ®Google Scholar
• Hongo I, Baba T, Oishi K, Phenol-soluble modulin alpha3 enhances the human neutrophil lysis mediated by panton-valentine leukocidin. J Infect Dis 2009;200:715-23
   PubMed Web of Science ®Google Scholar
• Stranger-Jones YK, Bae T, Schneewind O. Vaccine assembly from surface proteins of Staphylococcus aureus. Proc Natl Acad Sci USA 2006;103:16942-7
   PubMed Web of Science ®Google Scholar
• Mazmanian SK, Liu G, Ton-That H, Schneewind O. Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science 1999;285:760-3
   PubMed Web of Science ®Google Scholar
• Rohde H, Burandt EC, Siemssen N, Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 2007;28:1711-20
   PubMed Web of Science ®Google Scholar
• Vuong C, Voyich JM, Fischer ER, Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 2004;6:269-75
   PubMed Web of Science ®Google Scholar
• McKenney D, Pouliot K, Wang Y, Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol 2000;83:37-44
   PubMed Web of Science ®Google Scholar
• Maira-Litran T, Kropec A, Goldmann DA, Pier GB. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun 2005;73:6752-62
   PubMed Web of Science ®Google Scholar
• Vuong C, Kocianova S, Voyich JM, A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem 2004;279:54881-6
   PubMed Web of Science ®Google Scholar
• Spellberg B, Ibrahim AS, Yeaman MR, The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus. Infect Immun 2008;76:4574-80
   PubMed Web of Science ®Google Scholar
• Posey JE, Gherardini FC. Lack of a role for iron in the Lyme disease pathogen. Science 2000;288:1651-3
   PubMed Web of Science ®Google Scholar
• Skaar EP, Schneewind O. Iron-regulated surface determinants (Isd) of Staphylococcus aureus: stealing iron from heme. Microbes Infect 2004;6:390-7
   Google Scholar
• Stauff DL, Skaar EP. The heme sensor system of Staphylococcus aureus. Contrib Microbiol 2009;16:120-35
   PubMedGoogle Scholar
• Benjamin DK, Schelonka R, White R, A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin. J Perinatol 2006;26:290-5
   PubMed Web of Science ®Google Scholar
• Rupp ME, Holley HP Jr, Lutz J, Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2007;51:4249-54
   PubMed Web of Science ®Google Scholar
• McDevitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 1994;11:237-48
   PubMed Web of Science ®Google Scholar
• Foster TJ, Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998;6:484-8
   PubMed Web of Science ®Google Scholar
• Vernachio JH, Bayer AS, Ames B, Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo. Antimicrob Agents Chemother 2006;50:511-8
   PubMed Web of Science ®Google Scholar
• Josefsson E, Hartford O, O'Brien L, Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 2001;184:1572-80
   PubMed Web of Science ®Google Scholar
• Bloom B, Schelonka R, Kueser T, Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants. Pediatr Infect Dis J 2005;24:858-66
   PubMed Web of Science ®Google Scholar
• DeJonge M, Burchfield D, Bloom B, Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. J Pediatr 2007;151:260-5, 5 e1
   PubMed Web of Science ®Google Scholar
• Patti JM. A humanized monoclonal antibody targeting Staphylococcus aureus. Vaccine 2004;22(Suppl 1):S39-43
   PubMedGoogle Scholar
• Weems JJ Jr, Steinberg JP, Filler S, Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2006;50:2751-5
   PubMed Web of Science ®Google Scholar
• Burnie JP, Matthews RC, Carter T, Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect Immun 2000;68:3200-9
   PubMed Web of Science ®Google Scholar
• Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev 2005;18:521-40
   PubMed Web of Science ®Google Scholar
• Standiford TJ, Arenberg DA, Danforth JM, Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect Immun 1994;62:119-25
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Tawaratsumida K, Kariya H, Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol 2006;177:3162-9
   PubMed Web of Science ®Google Scholar
• Gross M, Cramton SE, Gotz F, Peschel A. Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect Immun 2001;69:3423-6
   PubMed Web of Science ®Google Scholar
• Weisman LE, Thackray HM, Garcia-Prats JA, Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates. Antimicrob Agents Chemother 2009;53:2879-86
   PubMed Web of Science ®Google Scholar
• Ragle BE, Bubeck Wardenburg J. Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect Immun 2009;77:2712-8
   PubMed Web of Science ®Google Scholar
• McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 2001;55:77-104
   PubMed Web of Science ®Google Scholar
• LeClaire RD, Hunt RE, Bavari S. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination. Infect Immun 2002;70:2278-81
   PubMed Web of Science ®Google Scholar
• Lowell GH, Colleton C, Frost D, Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines. Infect Immun 1996;64:4686-93
   PubMed Web of Science ®Google Scholar
• Alksne LE, Projan SJ. Bacterial virulence as a target for antimicrobial chemotherapy. Curr Opin Biotechnol 2000;11:625-36
   PubMed Web of Science ®Google Scholar
• Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 2003;48:1429-49
   PubMed Web of Science ®Google Scholar
• Otto M. Quorum-sensing control in Staphylococci – a target for antimicrobial drug therapy? FEMS Microbiol Lett 2004;241:135-41
   PubMed Web of Science ®Google Scholar
• Vuong C, Kocianova S, Yao Y, Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J Infect Dis 2004;190:1498-505
   PubMed Web of Science ®Google Scholar
• Vuong C, Saenz HL, Gotz F, Otto M. Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis 2000;182:1688-93
   PubMed Web of Science ®Google Scholar
• Ji G, Beavis R, Novick RP. Bacterial interference caused by autoinducing peptide variants. Science 1997;276:2027-30
   PubMed Web of Science ®Google Scholar
• Lyon GJ, Mayville P, Muir TW, Novick RP. Rational design of a global inhibitor of the virulence response in Staphylococcus aureus, based in part on localization of the site of inhibition to the receptor-histidine kinase, AgrC. Proc Natl Acad Sci USA 2000;97:13330-5
   PubMed Web of Science ®Google Scholar
• Park J, Jagasia R, Kaufmann GF, Infection control by antibody disruption of bacterial quorum sensing signaling. Chem Biol 2007;14:1119-27
   PubMed Web of Science ®Google Scholar
• Otto M. Antibodies to block staph virulence. Chem Biol 2007;14:1093-4
   PubMed Web of Science ®Google Scholar
• Gyimesi E, Bankovich AJ, Schuman TA, Staphylococcus aureus bound to complement receptor 1 on human erythrocytes by bispecific monoclonal antibodies is phagocytosed by acceptor macrophages. Immunol Lett 2004;95:185-92
   PubMed Web of Science ®Google Scholar
• Mohamed N, Jones SM, Casey LS, Heteropolymers: a novel technology against blood-borne infections. Curr Opin Mol Ther 2005;7:144-50
   PubMed Web of Science ®Google Scholar
• Lindorfer MA, Hahn CS, Foley PL, Taylor RP. Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications. Immunol Rev 2001;183:10-24
   PubMed Web of Science ®Google Scholar
• Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-20
   PubMed Web of Science ®Google Scholar
• von Eiff C, Becker K, Machka K, Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001;344:11-6
   PubMed Web of Science ®Google Scholar
• Coates T, Bax R, Coates A. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother 2009;64:9-15
   PubMed Web of Science ®Google Scholar
• Clarke SR, Brummell KJ, Horsburgh MJ, Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J Infect Dis 2006;193:1098-108
   PubMed Web of Science ®Google Scholar
• Schaffer AC, Solinga RM, Cocchiaro J, Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model. Infect Immun 2006;74:2145-53
   PubMed Web of Science ®Google Scholar
• Goodyear CS, Silverman GJ. Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes. Proc Natl Acad Sci USA 2004;101:11392-7
   PubMed Web of Science ®Google Scholar
• Forsgren A, Nordstrom K. Protein A from Staphylococcus aureus: the biological significance of its reaction with IgG. Ann NY Acad Sci 1974;236:252-66
   PubMed Web of Science ®Google Scholar
• DeLeo FR, Otto M. An antidote for Staphylococcus aureus pneumonia? J Exp Med 2008;205:271-4
   PubMed Web of Science ®Google Scholar
• Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol 2005;3:948-58
   PubMed Web of Science ®Google Scholar
• Wang R, Braughton KR, Kretschmer D, Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007;13:1510-4
   PubMed Web of Science ®Google Scholar